CaMKII inhibition rescues proarrhythmic phenotypes in the model of human ankyrin-B syndrome.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Heart Rhythm

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.hrthm.2012.08.026PMID 23059182PMCID PMC3630478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ankyrin-B reduction enhances Ca spark-mediated SR Ca release promoting cardiac myocyte arrhythmic activity.

  2012cited by this paper
• Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias.

  2012cited by this paper
• Defects in Cytoskeletal Signaling Pathways, Arrhythmia, and Sudden Cardiac Death

  2012cited by this paper
• Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias.

  2011cited by this paper
• Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.

  2011cited by this paper
• Catecholamine-Independent Heart Rate Increases Require Ca2+/Calmodulin-Dependent Protein Kinase II

  2011cited by this paper
• Interactions Between Ankyrin-G, Plakophilin-2, and Connexin43 at the Cardiac Intercalated Disc

  2011cited by this paper
• Defects in Ankyrin-Based Membrane Protein Targeting Pathways Underlie Atrial Fibrillation

  2011cited by this paper
• Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation.

  2010cited by this paper
• A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice.

  2010cited by this paper
• CaV1.2 β-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations

  2010cited by this paper
• Ryanodine Receptor Phosphorylation by Calcium/Calmodulin-Dependent Protein Kinase II Promotes Life-Threatening Ventricular Arrhythmias in Mice With Heart Failure

  2010cited by this paper
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Ankyrin-B Regulates Kir6.2 Membrane Expression and Function in Heart*

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Regulation of the ankyrin-B-based targeting pathway following myocardial infarction.

  2009cited by this paper
• Dual role of KATP channel C-terminal motif in membrane targeting and metabolic regulation

  2009cited by this paper
• Calmodulin kinase II is required for fight or flight sinoatrial node physiology

  2009cited by this paper
• miR-1 Overexpression Enhances Ca2+ Release and Promotes Cardiac Arrhythmogenesis by Targeting PP2A Regulatory Subunit B56α and Causing CaMKII-Dependent Hyperphosphorylation of RyR2

  2009cited by this paper
• Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.

  2009cited by this paper
• Voltage-gated Nav channel targeting in the heart requires an ankyrin-G–dependent cellular pathway

  2008cited by this paper
• Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease

  2008cited by this paper
• Obscurin Targets Ankyrin-B and Protein Phosphatase 2A to the Cardiac M-line*

  2008cited by this paper
• Molecular basis for PP2A regulatory subunit B56α targeting in cardiomyocytes

  2007cited by this paper
• Defining the Cellular Phenotype of “Ankyrin-B Syndrome” Variants: Human ANK2 Variants Associated With Clinical Phenotypes Display a Spectrum of Activities in Cardiomyocytes

  2007cited by this paper
• Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes.

  2007cited by this paper
• Targeting and Stability of Na/Ca Exchanger 1 in Cardiomyocytes Requires Direct Interaction with the Membrane Adaptor Ankyrin-B*

  2007cited by this paper
• Ankyrin-B Syndrome: Enhanced Cardiac Function Balanced by Risk of Cardiac Death and Premature Senescence

  2007cited by this paper
• Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.

  2006cited by this paper
• Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor

  2005cited by this paper
• Ankyrin-B Coordinates the Na/K ATPase, Na/Ca Exchanger, and InsP3 Receptor in a Cardiac T-Tubule/SR Microdomain

  2005cited by this paper
• Calmodulin kinase II inhibition protects against structural heart disease

  2005cited by this paper
• A cardiac arrhythmia syndrome caused by loss of ankyrin-B function

  2004cited by this paper
• Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor

  2004cited by this paper
• Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.

  2004cited by this paper
• Obscurin is a ligand for small ankyrin 1 in skeletal muscle.

  2003cited by this paper
• Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

  2003cited by this paper
• Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

  2002cited by this paper
• Measurement of heart rate and Q-T interval in the conscious mouse.

  1998cited by this paper
• Small, Membrane-bound, Alternatively Spliced Forms of Ankyrin 1 Associated with the Sarcoplasmic Reticulum of Mammalian Skeletal Muscle

  1997cited by this paper
• Differential regulation of two types of intracellular calcium release channels during end-stage heart failure.

  1995cited by this paper
• Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.

  1995cited by this paper
• The cardiac Na+-Ca2+ exchanger binds to the cytoskeletal protein ankyrin.

  1993cited by this paper

• Reappraisal of ANK2 Variants in Cardiovascular Diseases: Uncovering Mechanisms and Future Directions

  2025cites this paper
• Loss of protein phosphatase 2A regulatory subunit PPP2R5A is associated with increased incidence of stress-induced proarrhythmia

  2024cites this paper
• CaMKII as a Therapeutic Target in Cardiovascular Disease

  2022influential citation
• Role of Ca^2+ in healthy and pathologic cardiac function: from normal excitation–contraction coupling to mutations that cause inherited arrhythmia

  2022cites this paper
• Mechanisms underlying the role of ankyrin-B in cardiac and neurological health and disease

  2022cites this paper
• Mouse models of spontaneous atrial fibrillation

  2022cites this paper
• Novel Biosensor Identifies Ruxolitinib as a Potent and Cardioprotective CaMKII Inhibitor

  2022cites this paper
• Genetic and Molecular Basis of Cardiac Arrhythmias

  2020cites this paper
• Human ankyrins and their contribution to disease biology: An update

  2020cites this paper
• Human ankyrins and their contribution to disease biology: An update

  2020cites this paper
• Protein Phosphatase 2A Regulates Cardiac Na+ Channels

  2019cites this paper
• Ankyrin-B Q1283H Variant Linked to Arrhythmias Via Loss of Local Protein Phosphatase 2A Activity Causes Ryanodine Receptor Hyperphosphorylation

  2018cites this paper
• 23 – Function and Dysfunction of Ion Channel Membrane Trafficking and Posttranslational Modification

  2018cites this paper
• Spectrin-based pathways underlying electrical and mechanical dysfunction in cardiac disease

  2018cites this paper
• Ankyrins and Spectrins in Cardiovascular Biology and Disease

  2017cites this paper
• Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

  2017cites this paper
• CaMKII: The molecular villain that aggravates cardiovascular disease

  2017cites this paper
• The evolving role of ankyrin-B in cardiovascular disease.

  2017cites this paper
• The Arrhythmogenic Calmodulin Mutation D129G Dysregulates Cell Growth, Calmodulin-dependent Kinase II Activity, and Cardiac Function in Zebrafish*

  2016cites this paper
• Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal.

  2016cites this paper
• Roles and regulation of protein phosphatase 2A (PP2A) in the heart.

  2016cites this paper
• Elevated local [Ca2+] and CaMKII promote spontaneous Ca2+ release in ankyrin-B-deficient hearts.

  2016cites this paper
• Syddansk Universitet The arrhythmogenic calmodulin mutation D 129 G dysregulates cell growth , calmodulin-dependent kinase II activity , and cardiac function in zebrafish

  2016cites this paper
• Molecular Pathways and Animal Models of Arrhythmias

  2016cites this paper
• Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart.

  2016cites this paper
• Dysfunction in the &bgr;II Spectrin–Dependent Cytoskeleton Underlies Human Arrhythmia

  2015cites this paper
• Voltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In Vivo

  2015cites this paper
• Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart

  2015cites this paper
• Role of CaMKII in cardiac arrhythmias.

  2015cites this paper
• Eps15 Homology Domain-containing Protein 3 Regulates Cardiac T-type Ca2+ Channel Targeting and Function in the Atria*

  2015influential citation
• Atrial Fibrillation Therapy Now and in the Future: Drugs, Biologicals, and Ablation

  2014cites this paper
• EHD3-Dependent Endosome Pathway Regulates Cardiac Membrane Excitability and Physiology

  2014cites this paper
• Toward a hierarchy of mechanisms in CaMKII-mediated arrhythmia

  2014influential citation
• CaMKII-dependent regulation of cardiac Na+ homeostasis

  2014influential citation
• Hyperphosphorylation of RyRs Underlies Triggered Activity in Transgenic Rabbit Model of LQT2 Syndrome

  2014cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis.

  2013cites this paper
• The year in review of clinical cardiac electrophysiology.

  2013cites this paper
• Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system.

  2013cites this paper
• Current and Emerging Antiarrhythmic Drug Therapy for Ventricular Tachycardia

  2013influential citation
• The year in review of clinical cardiac electrophysiology.

  2013cites this paper
• The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias

  2013cites this paper
• Ankyrin-G Participates in INa Remodeling in Myocytes from the Border Zones of Infarcted Canine Heart

  2013cites this paper
• Mechanisms of Altered Ca2+ Handling in Heart Failure

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Luo and Anderson Mechanisms of Altered Ca 2 + Handling in Heart Failure

  2013cites this paper
• CaMKII and ryanodine receptor as new antiarrhythmic targets.

  2012cites this paper
• Molecular Mechanisms Underlying Cardiac Protein Phosphatase 2A Regulation in Heart*

  2012cites this paper
• Integrative Physiology Methods and Results: We Identify the Endosome-based Eps15 Homology Domain 3 (ehd3) Pathway as Essential for Cardiac Physiology. Ehd3-deficient Hearts Display Structural and Functional Defects including Bradycardia and Rate Variability, Conduction Block, and Blunted Response to

  year unknowncites this paper